miR-1296 in Human Cancers: Context-Dependent Tumor Suppressor and Oncogene Orchestrated by ceRNA Networks
DOI:
https://doi.org/10.62382/jcbt.v2i4.82Keywords:
Cancer, miR-1296, Molecular function, Tumor suppressor, OncogeneAbstract
Abnormal regulation of microRNA (miRNA) production is increasingly recognized as a hallmark of cancer development. Genetic alterations, disrupted transcriptional control, and deficiencies in processing machinery all contribute to changes in miRNA levels. Depending on the cellular environment, a single miRNA may act either in favor of tumor growth or as a barrier against malignancy. These small RNAs influence key oncogenic features, including uncontrolled cell division, suppression of growth-inhibitory pathways, evasion of programmed cell death, metastatic spread, and angiogenesis. Because of this broad impact, numerous studies have explored the potential of miRNAs as biomarkers for early diagnosis and prognosis, although further validation is still required before clinical translation. Among these regulators, hsa-miR-1296 has recently gained attention. Both strands of its precursor, miR-1296-5p and miR-1296-3p, are involved in modulating multiple signaling cascades across different tumor types. Depending on tissue context, miR-1296 can function as either a tumor suppressor or, less frequently, as an oncogenic factor by targeting genes central to cell-cycle progression, migration, invasion, and therapy resistance. Evidence from breast, lung, liver, colorectal, gastric, prostate, and bone cancers shows that miR-1296 interacts with networks of protein-coding genes and noncoding RNAs, shaping tumor behavior and influencing patient outcomes. Relevant studies were identified through searches in PubMed and Scopus databases up to 2025, focusing on experimental and clinical investigations of miR-1296 in human cancers and its ceRNA-mediated regulatory mechanisms. This review summarizes the current knowledge of miR-1296 biology and highlights its dual role in cancer, as well as its emerging value as a diagnostic and therapeutic candidate for precision oncology.
Downloads
References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015, 136(5), E359-86. DOI: 10.1002/ijc.29210
Zafar A, Khatoon S, Khan MJ, Abu J, Naeem A. Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discover Oncology. 2025, 16(1), 607. DOI: 10.1007/s12672-025-02198-8
Vosoughi P, Naghib SM, Takdehghan G. Machine learning in cancer prognostic and diagnostic biomarkers: A promising approach for early cancer detection. Sensors and Actuators Reports. 2025, 10, 100385. DOI: 10.1016/j.snr.2025.100385
O'Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Frontiers in Endocrinology. 2018, 9, 402. DOI: 10.3389/fendo.2018.00402
Seida M, Ogami K, Yoshino S, Suzuki HI. Fine Regulation of MicroRNAs in Gene Regulatory Networks and Pathophysiology. International Journal of Molecular Sciences. 2025, 26(7), 2861. DOI: 10.3390/ijms26072861
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993, 75(5), 843-54. DOI: 10.1016/0092-8674(93)90529-y
Yu J, Wang F. MicroRNAs: discovery, breakthrough, and innovation. Blood Science (Baltimore, Md.). 2024, 6(4), e00210. DOI: 10.1097/BS9.0000000000000210
Jang JH, Lee TJ. The role of microRNAs in cell death pathways. Yeungnam University Journal of Medicine. 2021, 38(2), 107-117. DOI: 10.12701/yujm.2020.00836
Mohanty JN, Sahoo S, Routray SP, Bhuyan R. Does the diverse source of miRNAs affect human health? An approach towards diagnosis and therapeutic management. Gene Reports. 2022, 28, 101656. DOI: 10.1016/j.genrep.2022.101656
He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, et al. miRNA-based biomarkers, therapies, and resistance in Cancer. International Journal of Biological Sciences. 2020, 16(14), 2628-2647. DOI: 10.7150/ijbs.47203
Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. Journal of Cellular Physiology. 2019, 234(5), 5451-5465. DOI: 10.1002/jcp.27486
Liu L, Chen Q, Lai R, Wu X, Wu X, Liu F, et al. Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer. Journal of Biomedical Research. 2010, 24(3), 187-97. DOI: 10.1016/S1674-8301(10)60028-0
Kumar V, Gupta S, Varma K, Chaurasia A, Sachan M. Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction. Journal of Gynecologic Oncology. 2022, 33(4), e49. DOI: 10.3802/jgo.2022.33.e49
Soliman B, Salem A, Ghazy M, Abu-Shahba N, El Hefnawi M. Bioinformatics functional analysis of let-7a, miR-34a, and miR-199a/b reveals novel insights into immune system pathways and cancer hallmarks for hepatocellular carcinoma. Tumour Biology. 2018, 40(5), 1010428318773675. DOI: 10.1177/1010428318773675
Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. International Journal of Cancer. 2010, 126(6), 1283-90. DOI: 10.1002/ijc.25014
Chen G, He M, Yin Y, Yan T, Cheng W, Huang Z, et al. miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer. Cancer Cell International. 2017, 17(1), 95. DOI: 10.1186/s12935-017-0466-y
Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, et al. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Oncotarget. 2016, 7(15), 19519-30. DOI: 10.18632/oncotarget.6961
Shan X, Wen W, Zhu D, Yan T, Cheng W, Huang Z, et al. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression. PLoS One. 2017, 12(1), e0170298. DOI: 10.1371/journal.pone.0170298
Deng HQ, Xie CP, Ye Y, Du ZL. MicroRNA-1296 expression is associated with prognosis and inhibits cell proliferation and invasion by Wnt signaling in non-small cell lung cancer. Oncology Letters. 2020, 19(1), 623-630. DOI: 10.3892/ol.2019.11154
Hazari V, Samali SA, Izadpanahi P, Mollaei H, Sadri F. MicroRNA-98: the multifaceted regulator in human cancer progression and therapy. Cancer Cell International. 2024, 24(1), 209. DOI: 10.1186/s12935-024-03386-2
Guo F. Chapter Five - Drosha and DGCR8 in MicroRNA Biogenesis. The Enzymes. 2012, 32, 101-121. DOI: 10.1016/B978-0-12-404741-9.00005-2
Havens MA, Reich AA, Duelli DM, Hastings ML. Biogenesis of mammalian microRNAs by a non-canonical processing pathway. Nucleic Acids Research. 2012, 40(10), 4626-40. DOI: 10.1093/nar/gks026
Stavast CJ, Erkeland SJ. The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation. Cells. 2019, 8(11), 1465. DOI: 10.3390/cells8111465
Pong SK, Gullerova M. Noncanonical functions of microRNA pathway enzymes - Drosha, DGCR8, Dicer and Ago proteins. FEBS Letters. 2018, 592(17), 2973-2986. DOI: 10.1002/1873-3468.13196
Tang G. siRNA and miRNA: an insight into RISCs. Trends in Biochemical Sciences. 2005, 30(2), 106-114. DOI: 10.1016/j.tibs.2004.12.007
Yang JS, Lai EC. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Molecular Cell. 2011, 43(6), 892-903. DOI: 10.1016/j.molcel.2011.07.024
Sadri F, Hosseini SF, Aghayei A, Fereidouni M, Rezaei Z. The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers. DNA and Cell Biology. 2022, 41(9), 810-823. DOI: 10.1089/dna.2022.0274
Michlewski G, Cáceres JF. Post-transcriptional control of miRNA biogenesis. RNA. 2019, 25(1), 1-16. DOI: 10.1261/rna.068692.118
Shan W, Sun C, Zhou B, Guo E, Lu H, Xia M, et al. Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis. Oncotarget. 2016, 7(45), 72672-72684. DOI: 10.18632/oncotarget.12183
Tao Y, Ma C, Fan Q, Wang Y, Han T, Sun C. MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ. Journal of Cancer. 2018, 9(13), 2317-2326. DOI: 10.7150/jca.25427
Jia Y, Zhao LM, Bai HY, Zhang C, Dai SL, Lv HL, et al. The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer. Bioscience Reports. 2019, 39(1), BSR20181556. DOI: 10.1042/BSR20181556
Zhang G, Xia M, Guo J, Huang Y, Huang J, Wei K, et al. microRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2. Technology in Cancer Research & Treatment. 2021, 20, 1533033821990009. DOI: 10.1177/1533033821990009
Li G, Chen W, Gong Y, Wei T, Gong R, Zhu J, et al. Identification of Circulating Exosomal microRNAs Associated with Radioiodine Refractory in Papillary Thyroid Carcinoma. Journal of Personalized Medicine. 2022, 12(12), 2017. DOI: 10.3390/jpm12122017
Calin GA, Croce CM. MicroRNA signatures in human cancers. Nature Reviews. Cancer. 2006, 6(11), 857-66. DOI: 10.1038/nrc1997
Lettre G, Palmer CD, Young T, Ejebe KG, Allayee H, Benjamin EJ, et al. Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genetics. 2011, 7(2), e1001300. DOI: 10.1371/journal.pgen.1001300
Pourmehran Y, Sadri F, Hosseini SF, Mohammadi Y, Rezaei Z. Exploring the influence of non-coding RNAs on NF-κB signaling pathway regulation in ulcerative colitis. Biomedicine & Pharmacotherapy. 2024, 179, 117390. DOI: 10.1016/j.biopha.2024.117390
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005, 435(7043), 828-833. DOI: 10.1038/nature03552
Fang LL, Wang XH, Sun BF, Zhang XD, Zhu XH, Yu ZJ, et al. Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review). International Journal of Molecular Medicine. 2017, 40(6), 1624-1630. DOI: 10.3892/ijmm.2017.3164
Ma YX, Shen N, Wicha MS, Luo M. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness. Cells. 2021, 10(9), 2415. DOI: 10.3390/cells10092415
Slabáková E, Culig Z, Remšík J, Souček K. Alternative mechanisms of miR-34a regulation in cancer. Cell Death & Disease. 2017, 8(10), e3100. DOI: 10.1038/cddis.2017.495
Garg M. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Expert Opinion on Therapeutic Targets. 2015, 19(2), 285-297. DOI: 10.1517/14728222.2014.975794
Liu Z, Zhu JM, Cao H, Ren H, Fang XD. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. International Journal of Oncology. 2012, 40(5), 1553-1560. DOI: 10.3892/ijo.2012.1342
Muluhngwi P, Klinge CM. Roles for miRNAs in endocrine resistance in breast cancer. Endocrine Related Cancer. 2015, 22(5), R279-300. DOI: 10.1530/ERC-15-0355
Singh S, Saini H, Sharma A, Gupta S, Huddar VG, Tripathi R. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Frontiers in Oncology. 2023, 13, 1155254. DOI: 10.3389/fonc.2023.1155254
Adams BD, Parsons C, Slack FJ. The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. Expert Opinion on Therapeutic Targets. 2016, 20(6), 737-753. DOI: 10.1517/14728222.2016.1114102
Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, et al. Breast Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians. 2022, 72(6), 524-541. DOI: 10.3322/caac.21863
Liu HJ, Ye H. Screening of the prognostic targets for breast cancer based co-expression modules analysis. Molecular Medicine Reports. 2017, 16(4), 4038-4044. DOI: 10.3892/mmr.2017.7063
Obidiro O, Battogtokh G, Akala EO. Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. Pharmaceutics. 2023, 15(7), 1796. DOI: 10.3390/pharmaceutics15071796
Albakr L, Alqahtani FY, Aleanizy FS, Alomrani A, Badran M, Alhindas H, et al. Improved delivery of miR-1296 loaded cationic nanoliposomes for effective suppression of triple negative breast cancer. Saudi Pharmaceutical Pournal: SPJ: The Official Publication of the Saudi Pharmaceutical Society. 2021, 29(5), 446-455. DOI: 10.1016/j.jsps.2021.04.007
Xie F, Xiong YY, Yan JY, Wang L, Yan W. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis. Bioengineered. 2022, 13(2), 1963-1974. DOI: 10.1080/21655979.2021.1995990
Jiang J, Shi SH, Zhang W, Li C, Sun L, Ge Q, et al. Circ_RPPH1 facilitates progression of breast cancer via miR-1296-5p/TRIM14 axis. Cancer Biology & Therapy. 2024, 25(1), 2360768. DOI: 10.1080/15384047.2024.2360768
Wang PE, Qu HJ, Wang L, Hu Z. Silencing of circUSPL1 represses breast cancer progression by targeting miR-1296-5p/MTA1 axis. Thoracic Cancer. 2023, 14(22), 2198-2209. DOI: 10.1111/1759-7714.15007
Zhou Y, Ma GX, Peng SJ, Tuo M, Li YM, Qin XX, et al. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis. Thoracic Cancer. 2021, 12(18), 2427-2438. DOI: 10.1111/1759-7714.14085
Zang HL, Li YH, Zhang X, Huang GM. Blocking circ_0000520 Suppressed Breast Cancer Cell Growth, Migration and Invasion Partially via miR-1296/SP1 Axis Both in vitro and in vivo. Cancer Management and Research. 2020, 12, 7783-7795. DOI: 10.2147/CMAR.S251666
Huang YX, Qian MP, Chu JH, Chen L, Jian W, Wang G. Identification of circRNA-miRNA-mRNA network in luminal breast cancers by integrated analysis of microarray datasets. Frontiers in Molecular Biosciences. 2023, 10, 1162259. DOI: 10.3389/fmolb.2023.1162259
Zhang P, Wang G, Lin ZL, Wu YS, Zhang J, Liu M, et al. Alcohol exposure induces chick craniofacial bone defects by negatively affecting cranial neural crest development. Toxicology Letters. 2017, 281, 53-64. 10.1016/j.toxlet.2017.09.010
Fiteni F, Anota A, Westeel V, Bonnetain F. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review. BMC Cancer. 2016, 16, 122. DOI: 10.1186/s12885-016-2152-1
Chang FY, Li JL, Sun Q, Wei SQ, Song YM. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer. Bioengineered. 2022, 13(4), 8806-8822. DOI: 10.1080/21655979.2022.2053810
Tu GX, Peng WL, Peng X, Zhao ZY, Shi S, Cai QD, et al. hsa_circ_0000519 promotes the progression of lung adenocarcinoma through the hsa-miR-1296-5p/DARS axis. American Journal of Cancer Research. 2023, 13(8), 3342-3367. PMCID: PMC10492121
Zhao Y, Deng LY, Xie Y, Wang WM, Chai Q, Wang GH. circRACGAP1 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through the miR-1296/CDK2 Pathway. Folia Biologica. 2024, 70(2), 104-112. DOI: 10.14712/fb2024070020104
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014, 64(1), 9-29. DOI: 10.3322/caac.21763
Chen Q, Zhou L, Ma D, Hou J, Lin YX, Wu J, et al. LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p/miR-1296-5p and FUS. Journal of Translational Medicine. 2022, 20(1), 356. DOI: 10.1186/s12967-022-03550-0
Nagy ZB, Barták BK, Kalmár A, Galamb O, Wichmann B, Dank M, et al. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Pathology Oncology Research: POR. 2019, 25(1), 97-105. DOI: 10.1007/s12253-017-0308-1
Bobowicz M, Skrzypski M, Czapiewski P, Marczyk M, Maciejewska A, Jankowski M, et al. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer. Clinical & Experimental Metastasis. 2016, 33(8), 765-773. DOI: 10.1007/s10585-016-9810-1
Ding L, Lan ZW, Xiong XH, Ao HS, Feng YT, Gu H, et al. The Dual Role of MicroRNAs in Colorectal Cancer Progression. International Journal of Molecular Sciences. 2018, 19(9), 2791. DOI: 10.3390/ijms19092791
Xu QR, Liu X, Liu ZK, Zhou ZY, Wang YF, Tu JF, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Molecular Cancer. 2017, 16(1), 103. DOI: 10.1186/s12943-017-0675-y
Liu Y, Tang H, Zhang YL, Wang Q, Li SY, Wang ZY, et al. Circular RNA hsa_circ_0000519 contributes to angiogenesis and tumor progression in hepatocellular carcinoma through the miR-1296/E2F7 axis. Human Cell. 2023, 36(2), 738-751. DOI: 10.1007/s13577-022-00854-7
Mei Y, You Y, Xia J, Gong JP, Wang YB. Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 2018, 48(4), 1443-1456. DOI: 10.1159/000492254
Xu QR, Liu X, Liu ZK, Zhou ZY, Wang YF, Tu JF, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Molecular Cancer. 2017, 16(1), 103. DOI: 10.1186/s12943-017-0675-y
Zhang DX, Fan DM. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncology. 2010, 6(4), 527-37. DOI: 10.2217/fon.10.21
Qu B, Liu JS, Peng ZY, Xiao Z, Li SJ, Wu JG, et al. CircSOD2 polarizes macrophages towards the M1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the miR-1296/STAT1 axis. Gene. 2023, 887, 147733. DOI: 10.1016/j.gene.2023.147733
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2018, 68(6), 394-424. DOI: 10.3322/caac.21492
Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Research. 2010, 70(7), 2809-18. DOI: 10.1158/0008-5472.CAN-09-4176
Fowler JR, Maani EV, Dunton CJ, Gasalberti DP, Jack BW. Cervical Cancer. StatPearls, 2025.
Zheng QL, Zhang J, Zhang T, Liu YX, Du XL, Dai X, et al. Hsa_circ_0000520 overexpression increases CDK2 expression via miR-1296 to facilitate cervical cancer cell proliferation. Journal of Translational Medicine. 2021, 19(1), 314. DOI: 10.1186/s12967-021-02953-9
Liu ZY, He WH, Gao JL, Luo JH, Huang X, Gao CF. Computational prediction and experimental validation of a novel synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing mechanisms in cervical cancer. Oncotarget. 2015, 6(10), 8019-35. DOI: 10.18632/oncotarget.3139
Ma GF, Zhang C, Luo WY, Zhao JL, Wang XB, Qian YW. Construction of microRNA-messenger networks for human osteosarcoma. Journal of Cellular Physiology. 2019, 234(8), 14145-14153. DOI: 10.1002/jcp.28107
Wang L, Hu KJ, Chao Y, Wang XL. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2. Journal of Cellular Biochemistry. 2020, 121(2), 2038-2046. DOI: 10.1002/jcb.29438
Grande E, Díez JJ, Zafon C, Capdevila J. Thyroid cancer: molecular aspects and new therapeutic strategies. Journal of Thyroid Research. 2012, 2012, 847108. DOI: 10.1155/2012/847108
Qiao DH, He XM, Deng X, Ji YC, Yang H, Cheng L, et al. Aberrant expression of five miRNAs in papillary thyroid carcinomas. Journal of Clinical Laboratory Analysis. 2021, 35(9), e23907. DOI: 10.1002/jcla.23907
Thenuwara G, Curtin J, Tian FR. Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review. Sensors. 2023, 23(24), 9842. DOI: 10.3390/s23249842
Zang HL, Li YH, Zhang X, Huang GM. Circ_0000517 Contributes to Hepatocellular Carcinoma Progression by Upregulating TXNDC5 via Sponging miR-1296-5p. Cancer Management and Research. 2020, 12, 3457-3468. DOI: 10.2147/CMAR.S244024
Pane K, Zanfardino M, Grimaldi AM, Baldassarre G, Salvatore M, Incoronato M, et al. Discovering Common miRNA Signatures Underlying Female-Specific Cancers via a Machine Learning Approach Driven by the Cancer Hallmark ERBB. Biomedicines. 2022, 10(6), 1306. DOI: 10.3390/biomedicines10061306
Rogucki M, Sidorkiewicz I, Niemira M, Dzięcioł JB, Buczyńska A, Adamska A, et al. Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer. Cancers (Basel). 2022, 14(11), 2679. DOI: 10.3390/cancers14112679
Niu MY, Li H, Li X, Yan XQ, Ma AJ, Pan XD, et al. Circulating exosomal miRNAs as novel biomarkers perform superior diagnostic efficiency compared with plasma miRNAs for large-artery atherosclerosis stroke. Frontiers in Pharmacology. 2021, 12, 791644. DOI: 10.3389/fphar.2021.791644
Jin J, Qin JJ, Qi XJ, Zhang JS, Zhang YL. Serum exosomal miRNA contributes to the diagnosis of leptomeningeal carcinomatosis. Journal of Neuro-oncology. 2025, 173(2), 419-428. DOI: 10.1007/s11060-025-04999-x
Nguyen HT, Kacimi SEO, Nguyen TL, Suman KH, Lemus-Martin R, Saleem H, et al. MiR-21 in the cancers of the digestive system and its potential role as a diagnostic, predictive, and therapeutic biomarker. Biology. 2021, 10(5), 417. DOI: 10.3390/biology10050417
Bamfield-Cummings S, Silva J, Karim ZA. A thematic analysis of prognostic, diagnostic, and therapeutic of circulating miRNA biomarkers in bortezomib-resistant multiple myeloma. SAGE Open Medicine. 2025, 13, 20503121251328486. DOI: 10.1177/20503121251328486
Moro L. Mitochondrial DNA and MitomiR Variations in Pancreatic Cancer: Potential Diagnostic and Prognostic Biomarkers. International Journal of Molecular Sciences (IJMS). 2021, 22(18), 9692. DOI: 10.3390/ijms22189692
Balakrishnan R, Subbarayan R, Kuppusamy M, Shrestha R, Radhakrishnan A, Chauhan A. Circulating miR‐542‐3p as a Prognostic Marker for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis. Journal of Cellular and Molecular Medicine. 2025, 29(14), e70748. DOI: 10.1111/jcmm.70748
Lee SC, Quinn A, Nguyen T, Venkatesh S, Quinn TP. A cross-cancer metastasis signature in the microRNA–mRNA axis of paired tissue samples. Molecular Biology Reports. 2019, 46(6), 5919-5930. DOI: 10.1007/s11033-019-05025-w
Chen L, Wong G. Novel tumor biomarker based on isomiR expression profiles. 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
Hoadley KA, Fan C, Wilkerson MD, Mose LE, Jefferys SR, Auman T, et al. Abstract SY12-03: Multi-tumor analysis of TCGA data identifies expression commonalities across tumor types. Cancer Research. 2013, 73(8_Supplement), SY12-03-SY12-03. DOI: 10.1158/1538-7445.AM2013-SY12-03
Liu HR, Li YY, Karsidag M, Tu T, Wang PP. Technical and Biological Biases in Bulk Transcriptomic Data Mining for Cancer Research. Journal of Cancer. 2025, 16(1), 34-43. DOI: 10.7150/jca.100922
Lauss M, Visne I, Kriegner A, Ringnér M, Jönsson G, Höglund M. Monitoring of technical variation in quantitative high-throughput datasets. Cancer Informatics. 2013, 12, 193-201. DOI: 10.4137/CIN.S12862
Liu HR, Guo Z, Wang PP. Genetic expression in cancer research: challenges and complexity. Gene Reports. 2024, 37, 102042. DOI: 10.1016/j.genrep.2024.102042
Uddin N, Binzel DW, Shu D, Fu TM, Guo PX. Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome. Acta Pharmaceutica Sinica. B. 2023, 13(4), 1383-1399. DOI: 10.1016/j.apsb.2022.11.019
Li D, Gong L, Lin H, Yao SR, Yin Y, Zhou ZF, et al. Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204. Cells. 2022, 11(19), 3065. DOI: 10.3390/cells11193065
O'Neill CP, Dwyer RM. Nanoparticle-based delivery of tumor suppressor microRNA for cancer therapy. Cells. 2020, 9(2), 521. DOI: 10.3390/cells9020521
Lanre S, Ekundayo F, Damilare O. Cancer diagnosis and prognosis using multi-Omics data: a data science and machine learning approach. World Journal of Advanced Research and Reviews. 2024, 24(3), 2052–2069. DOI: 10.30574/wjarr.2024.24.3.3876
Shoaib ASM, Nishat N, Raasetti M, Arif I. Integrative machine learning approaches for multi-omics data analysis in cancer research. International Journal of Health and Medical. 2024, 1(2), 26-39. DOI: 10.62304/ijhm.v1i2.149
Shang ZY, Ma ZY, Wu EQ, Chen XZ, Tuo BG, Li TL, et al. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer. Biomedicine & Pharmacotherapy. 2024, 170, 116030. DOI: 10.1016/j.biopha.2023.116030
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zahra Diba
This work is licensed under a Creative Commons Attribution 4.0 International License.
